Umang Shah Selected Research

Umang Shah Research Topics

Disease

5	Breast Neoplasms (Breast Cancer) 04/2024 - 08/2015
5	Neoplasms (Cancer) 01/2022 - 08/2015
2	Diabetes Mellitus 06/2023 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 04/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2024
1	Neuralgia (Stump Neuralgia) 04/2024
1	Hyperglycemia 04/2024
1	Wounds and Injuries (Trauma) 06/2023
1	Necrosis 06/2023
1	Ulcer 06/2023
1	Diabetic Foot 06/2023
1	Dengue (Dengue Fever) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Hyperplasia 01/2021
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Liposarcoma 04/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2017
1	Gambling (Pathological Gambling) 01/2017
1	Guillain-Barre Syndrome 09/2015
1	Botulism 09/2015
1	Disease Progression 09/2015
1	Miller Fisher Syndrome (Fisher Syndrome) 09/2015
1	Hypertension (High Blood Pressure) 02/2014
1	Mental Disorders (Mental Disorder) 04/2013
1	Nausea 04/2013
1	Vomiting 04/2013
1	Venous Thromboembolism 04/2013
1	Constipation 04/2013
1	Glioma (Gliomas) 04/2013
1	Diarrhea 04/2013
1	Brain Edema (Cerebral Edema) 04/2013
1	Seizures (Absence Seizure) 04/2013

Drug/Important Bio-Agent (IBA)

3	FlavonoidsIBA 04/2024 - 01/2022
2	EnzymesIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Aromatase (CYP19)IBA 01/2022 - 01/2022
2	Estrogens (Estrogen)FDA Link 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2020
2	eribulin FDA Link 04/2017 - 08/2015
2	AnthracyclinesIBA 04/2017 - 08/2015
2	taxaneIBA 04/2017 - 08/2015
1	morinIBA 04/2024
1	LuteolinIBA 04/2024
1	Protein SIBA 04/2024
1	taxifolinIBA 04/2024
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2024
1	gossypinIBA 04/2024
1	polyolIBA 04/2024
1	Acetylcarnitine (Alcar)IBA 04/2024
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2024
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 04/2024
1	Protein Kinase CIBA 04/2024
1	Becaplermin (PDGF-BB)FDA Link 06/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2023
1	Blood Glucose (Blood Sugar)IBA 06/2023
1	InterleukinsIBA 06/2023
1	CytokinesIBA 06/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2023
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2023
1	DiureticsIBA 01/2023
1	Antimalarials (Antimalarial Agents)IBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Atorvastatin (Lipitor)FDA Link 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Antisense OligonucleotidesIBA 01/2023
1	Central Nervous System StimulantsIBA 01/2023
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	AlkaloidsIBA 01/2022
1	N(6)- (4- amino- 3- iodobenzyl)adenosine- 5'- N- methyluronamideIBA 01/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Aromatase InhibitorsIBA 01/2022
1	LigandsIBA 01/2022
1	Testosterone Propionate FDA Link 01/2021
1	artemisinin (artemisinine)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020
1	Guanidine (Guanidine Nitrate)FDA Link 01/2018
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2017
1	Heroin (Diamorphine)IBA 01/2017
1	Type A Botulinum Toxins (Botox)FDA Link 09/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2015
1	Botulinum AntitoxinIBA 09/2015

Therapy/Procedure

7	Therapeutics 04/2024 - 02/2014
1	Surgical Amputation (Amputations) 06/2023
1	Debridement 06/2023
1	Drug Therapy (Chemotherapy) 04/2013